"10.1371_journal.pone.0088645","plos one","2014-03-26T00:00:00Z","Embriette R Hyde; Fernando Andrade; Zalman Vaksman; Kavitha Parthasarathy; Hong Jiang; Deepa K Parthasarathy; Ashley C Torregrossa; Gena Tribble; Heidi B Kaplan; Joseph F Petrosino; Nathan S Bryan","Integrative Molecular and Biomedical Sciences Graduate Program, Baylor College of Medicine, Houston, Texas, United States of America; Alkek Center for Metagenomics and Microbiome Research, Baylor College of Medicine, Houston, Texas, United States of America; Department of Microbiology and Molecular Genetics, Medical School, The University of Texas Health Science Center Houston, Houston, Texas, United States of America; Department of Periodontics, School of Dentistry, The University of Texas Health Science Center Houston, Houston, Texas, United States of America; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, United States of America; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center Houston, Houston, Texas, United States of America","Conceived and designed the experiments: NSB HBK JFP. Performed the experiments: ERH FA ZV KP HJ DKP ACT GT. Analyzed the data: ERH HJ GT HBK JFP NSB. Contributed reagents/materials/analysis tools: KP GT. Wrote the paper: NSB ERH GT HBK JFP.","The authors have read the journals policy and have the following conflicts: NSB and UTHealth have financial interests in Neogenis, Inc., a company that develops, produces, and sells nitric oxide related products intended to improve health, develop diagnostics for nitric oxide related metabolites, and performs commercial measurement of nitric oxide metabolites in biological samples. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials.","2014","03","Embriette R Hyde","ERH",11,TRUE,3,8,6,5,TRUE,TRUE,FALSE,0,NA,FALSE
